Managed Healthcare Executive February 21, 2025
Introduction
Despite advancements in vaccination and treatment, COVID-19 was responsible for 1.8% of all deaths in the United States during the week of January 4-11, 2025.1-3 The virus disproportionately affects high-risk populations including elderly and immunocompromised individuals and those with key chronic comorbidities.4-6
This article explores the burden of COVID-19, advancements in its prevention and treatment, inequities in health care access, potential strategies to address inequities and economic and societal impacts of the disease, with a particular focus on progression to severe disease and long COVID-19. Managed healthcare is uniquely situated to optimize patient outcomes, improve resource use and promote economic efficiency.
Burden of disease
On a global scale, peak SARS-CoV-2 infection rates have decreased since 2021.7 Despite this trend,...
Today's Sponsors
Today's Sponsor